Inventiva IVA
NASDAQ IVA
$3.56 +0.30 (+9.20%)
As of: Oct 21, 2026 · 11:41 AM EDT

Inventiva (IVA) Share-based Compensation (2020 - 2021)

Updated

Inventiva's Share-based Compensation came in at $31.16 million for FY2025, up 714.5% from $3.83 million in FY2024.

Analysis

Inventiva (IVA) Share-based Compensation (2020 - 2021) Analysis & Trends

Going back to FY2018, Inventiva's Share-based Compensation data covers 8 years.

  • Share-based Compensation carries a five-year compound annual growth rate of 96.2% (FY2020 to FY2025).
  • The FY2025 figure represents the highest annual Share-based Compensation in data going back to FY2018.
  • Per Business Quant, earlier years put Share-based Compensation at $3.83 million in FY2024 (-10.4%), $4.27 million in FY2023 (+88.7%), $2.26 million in FY2022 (-8.5%) and $2.47 million in FY2021 (+130.8%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 201.00 Mn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 458.00 Mn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 166.00 Mn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn 298.00 Mn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn -
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn -
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 165.00 Mn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn 231.00 Mn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 249.00 Mn
10 Inventiva 666.88 Mn -163.57 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 19,299.78
Mar 31, 2020 266,049.31
API Access

Inventiva Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=IVA&period=max&api_key=YOUR_API_KEY